Abstract
A series of novel substituted 2-(4-bromophenyl)-4-phenylthiazole compounds 5a–h were synthesized by a simplified two-step process. First, the selective and effective α-bromination of substituted acetophenone moieties with N-bromo succinamide was done followed by treating of substituted 2-bromo-1-phenylethan-1-one with 4-bromobenzothiamide under microwave irradiation. The structures of the newly synthesized compounds were confirmed by IR, 1H NMR, 13C NMR, mass spectra and C, H, N analysis. Further, all the synthesized compounds 5a–h were evaluated for xanthine oxidase inhibition. Among all the tested compounds, 5f was found to be highly potent (IC50 = 0.100 ± 0.08 µM) followed by 5e (IC50 = 0.145 ± 1.42 µM), compared to the standard allopurinol (IC50 = 0.150 ± 0.07 µM), which is evident from in vitro and in silico analysis.
Similar content being viewed by others
References
V. Lakshmi Ranganatha, A. Bushra Begum, P. Naveen, F. Zameer, R. Hegdekatte, S.A. Khanum, Synthesis, xanthine oxidase inhibition, and antioxidant screening of benzophenone tagged thiazolidinone analogs. Arch. Pharm. Chem. Life Sci. 347, 589–598 (2014)
B.A. Bushra, B. Muneera, R.V. Lakshmi, T. Prashanth, Z. Farhan, H. Raghavendra, A.K. Shaukath, Synthesis, antioxidant and xanthine oxidase inhibitory activity of 5-[4-[2-(5-Ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione derivatives. Arch. Pharm. Chem. Life Sci. 347, 247–255 (2014)
W.H. Chung, C.W. Wang, R.L. Dao, Severe cutaneous adverse drug reactions. J. Dermatol. 43, 758–766 (2016)
H.D. Gurupadaswamy, V. Girish, F. Zameer, R. Hegdekatte, J.B. Chauhan, S.A. Khanum, Synthesis of pyrimidones and evaluation of their xanthine oxidase inhibitory and anti-oxidant activities. Arch. Pharm. Chem. Life Sci. 346, 805–811 (2013)
C.E. Berry, J.M. Hare, Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555, 589–606 (2004)
L.D. Kong, Y. Zhang, X. Pan, R.X. Tan, C.H.K. Cheng, Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from sinofranchetia chinensis. Cell. Mol. Life Sci. 57, 500–505 (2000)
B. Halliwell, J.M.C. Gutteridge, C.E. Cross, Free radicals, antioxidants, and human disease. J. Lab. Clin. Med. 119, 598–620 (1992)
T. Prashanth, B.R. Vijay Avin, P. Thirusangu, V. Lakshmi Ranganatha, B.T. Prabhakar, J.N. Narendra Sharath Chandra, S.A. Khanum, Synthesis of coumarin analogs appended with quinoline and thiazole moiety and their apoptogenic role against murine ascitic carcinoma. Biomed. Pharmacother. 112, 108707 (2019)
Y.H.E. Mohammed, V.H. Malojirao, P. Thirusangu, M. Al-Ghorbani, B.T. Prabhakar, S.A. Khanum, The novel 4-phenyl-2-phenoxyacetamide thiazoles modulates the tumor hypoxia leading to the crackdown of neoangiogenesis and evoking the cell death. Eur. J. Med. Chem. 143, 1826–1839 (2018)
H.A. Khamees, Y.H.E. Mohammed, S. Ananda, F.H. Al-Ostoot, Y. Sangappa, S. Alghamdi, S.A. Khanum, M. Madegowda, Effect of o-difluoro and p-methyl substituents on the structure, optical properties and anti-inflammatory activity of phenoxy thiazole acetamide derivatives theoretical and experimental studies. J. Mol. Struct. 1199, 127024 (2020)
M. Al-Ghorbani, H.A. Alghamdi, S.A. Khanum, A review on anticancer potential of thiazole-heterocyclic hybrid compounds. Eur. J. Biomed. Pharm. Sci. 5, 122–128 (2018)
N. Siddiqui, M.F. Arshad, W. Ahsan et al., Thiazoles: a valuable insight into the recent advances and biological activities. Int. J. Pharm. Sci. Drug Res. 1, 136–143 (2009)
M.S. Masoud, A.E. Ali, N.M. Nasr, Chemistry, classification, pharmacokinetics, clinical uses, and analysis of beta-lactam antibiotics: a review. J Chem Pharm Res. 6, 58 (2014)
M.A.M.A. Shaikh, M. Raghuwanshi, M. Khurshid, S. Nazim, A.A.A. Rafique, Schiff’s bases and amides of selected five membered heterocyclic compounds: a review. J. Chem. Pharm. Res. 5, 14–25 (2013)
H.A. Khamees, Y.H.E. Mohammed, A. Swamynayaka, F.H. Al-Ostoot, Y. Sert, S. Alghamdi, S.A. Khanum, M. Madegowda, Molecular structure, DFT, vibrational spectra with fluorescence effect, hirshfeld surface, docking simulation and antioxidant activity of thiazole derivative. Chem. Select. 4, 4544–4558 (2019)
P. Thirusangu, V. Vigneshwaran, T. Prashanth, B.R. VijayAvin, V.H. Malojirao, H. Rakesh, S.A. Khanum, R. Mahmood, B.T. Prabhakar, Angiogenesis BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1a proteasomal degradation. Angiogenesis 1, 55–71 (2017)
H.M. Kramer, G. Curhan, The association between gout and nephrolithiasis: the national health and nutrition examination survey III, 1988–1994. Am. J. Kidney Dis. 40, 37–42 (2002)
K.R. Sathisha, S.A. Khanum, J.N. Narendra Sharath Chandra, F. Ayisha, S. Balaji, K. Gopal Marathe, G. Shubha, K.S. Rangappa, Bioorg. Med. Chem. 19, 211–220 (2010)
M.K. Reinders, T.L. Jansen, Management of hyperuricemia in gout: focus on febuxostat. Clin. Interv. Aging. 05, 7–18 (2010)
G. Kaur, J.V. Singh, M.K. Gupta, K. Bhagat, H.K. Gulati, A. Singh, P.M.S. Bedi, H. Singh, S. Sharma, Med. Chem. Res. 29, 83–93 (2020)
M.R. Ali, S. Kumar, O. Afzal, N. Shalmali, M. Sharma, S. Bawa, Xanthine oxidase inhibitory activity of aminothiazole. Chem. Biol. Drug Des. 87, 508–516 (2016)
S.A. Khanum, S. Shashikanth, B.S. Sudha, Microwave-assisted synthesis of 2-amino and 2-azetidinonyl-5-(2-benzoyl-phenoxymethyl)-1,3,4-oxadiazoles. Heteroat. Atom Chem. 15, 37 (2004)
X.-Y. Guan, Z. Al-Misbaa, K.-W. Huang, Arab. J. Chem. 8, 892–896 (2015)
K. Okamoto, B.T. Eger, T. Nishino, S. Kondo, E.F. Pai, T. Nishino, An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J. Biol. Chem. 278, 1848–1855 (2003)
G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, A.J. Olson, AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009)
N.M. O’Boyle, M. Banck, C.A. James, C. Morley, T. Vandermeersch, G.R. Hutchison, Open babel: an open chemical toolbox. J. Cheminf. 03, 1–4 (2011)
O. Trott, A.J. Olson, AutoDock Vina, improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010)
M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, E. Lindahl, High performance molecular simulations through multi-level parallelism from laptops to supercomputers. GROMACS SoftwareX 1, 19–25 (2015)
S.V. Zoete, M.A. Cuendet, A. Grosdidier, O. Michielin, Swiss param, a fast force field generation tool for small organic molecules. J. Comput. Chem. 32, 2359–2368 (2011)
P.J. Turner, XMGRACE, Version 5.1. 19. Center for Coastal and Land-Margin Research (Oregon Graduate Institute of Science and Technology, Beaverton, OR, 2005)
R. Kumari, R. Kumar, A GROMACS tool for high-throughput MM-PBSA calculations g_mmpbsa. Open-source drug discovery consortium, lynn A. J. Chem. Inf. Model. 54, 1951–1962 (2014)
B. Sander, A. Nizam, L.P. Garrison Jr., M.J. Postma, M.E. Halloran, Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. J. Natl. Lib. Med. 12, 226–233 (2009)
P. Schyman, R. Liu, V. Desai, A. Wallqvist, vNN web server for ADMET predictions. J. Front. Pharmacol. 4, 889 (2017)
Acknowledgements
All authors thank the University of Mysore, Mysuru, and JSS Academy of Higher Education and Research, Mysuru, for providing facilities to carry out the biological activity. Shaukath Ara Khanum thankfully acknowledges the financial support provided by VGST, Bangalore, under CISEE Programme [Project sanction order: No. VGST/CISEE/282].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Rights and permissions
About this article
Cite this article
Jyothi, M., Khamees, H.A., Patil, S.M. et al. Microwave-Assisted Synthesis, Characterization, Docking Studies and Molecular Dynamic of Some Novel Phenyl Thiazole Analogs as Xanthine Oxidase Inhibitor. J IRAN CHEM SOC 19, 3919–3933 (2022). https://doi.org/10.1007/s13738-022-02574-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-022-02574-z